Yeon-Soo Kim

Yeon-Soo Kim


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
MLmin jung Lee
min jung Lee
GAGaurav Agrahari
Gaurav Agrahari
Hae-Young KimHae-Young Kim
Hae-Young Kim
EAEun-Joo An
Eun-Joo An
KCKyung-Hee Chun
Kyung-Hee Chun
TKTae-Yoon Kim
Tae-Yoon Kim

23 November 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
JYJi Won Yang
Ji Won Yang
YSYoojin Seo
Yoojin Seo
TSTae-Hoon Shin
Tae-Hoon Shin
JAJi-Su Ahn
Ji-Su Ahn
SOSu-Jeong Oh
Su-Jeong Oh
HKHyung-Sik Kim
Hyung-Sik Kim
The immunoregulatory abilities of mesenchymal stem cells (MSCs) have been investigated in various autoimmune and allergic diseases. However, the therapeutic benefits observed in preclinical settings have not been reproducible in clinical trials. This discrepancy is due to insufficient efficacy of MSCs in harsh microenvironments, as well as batch-dependent variability in potency. Therefore, to achieve more beneficial and uniform outcomes, novel strategies are required to potentiate the therapeutic effect of MSCs. One of simple strategies to augment cellular function is genetic manipulation. Several studies showed that transduction of antioxidant enzyme into cells can increase anti-inflammatory effects. Therefore, we evaluated the immunoregulatory abilities of MSCs introduced with extracellular superoxide dismutase 3 (SOD3) in the present study. SOD3-overexpressed MSCs (SOD3-MSCs) reduced the symptoms of murine model of atopic dermatitis (AD)-like inflammation, as well as the differentiation and activation of various immune cells involved in AD progression. Interestingly, extracellular vesicles (EVs) isolated from SOD3-MSCs delivered SOD3 protein. EVs carrying SOD3 also exerted improved therapeutic efficacy, as observed in their parent cells. These results suggest that MSCs transduced with SOD3, an antioxidant enzyme, as well as EVs isolated from modified cells, might be developed as a promising cell-based therapeutics for inflammatory disorders.

6 June 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JKJiyoung Kim
Jiyoung Kim
YKYeon-Soo Kim
Yeon-Soo Kim
Human immunodeficiency virus type 1 (HIV-1) Tat, an important regulator of viral transcription, interacts with diverse cellular proteins and promotes or inhibits cell proliferation. Here, we show that ribosomal protein S3 (RPS3) plays an important role in mitosis through an interaction with α-tubulin and that Tat binds to and inhibits the localization of RPS3 in the mitotic spindle during mitosis. RPS3 colocalized with α-tubulin around chromosomes in the mitotic spindle. Depletion of RPS3 promoted α-tubulin assembly, while overexpression of RPS3 impaired α-tubulin assembly. Depletion of RPS3 resulted in aberrant mitotic spindle formation, segregation failure, and defective abscission. Moreover, ectopic expression of RPS3 rescued the cell proliferation defect in RPS3-knockdown cells. HIV-1 Tat interacted with RPS3 through its basic domain and increased the level of RPS3 in the nucleus. Expression of Tat caused defects in mitotic spindle formation and chromosome assembly in mitosis. Moreover, the localization of RPS3 in the mitotic spindle was disrupted when HIV-1 Tat was expressed in HeLa and Jurkat cells. These results suggest that Tat inhibits cell proliferation via an interaction with RPS3 and thereby disrupts mitotic spindle formation during HIV-1 infection. These results might provide insight into the mechanism underlying lymphocyte pathogenesis during HIV-1 infection.

1 June 2013 in Journal of Aerosol Medicine and Pulmonary Drug Delivery
Verified
Journal Article
Closed access
SHSoon-Kyung Hwang
Soon-Kyung Hwang
SCSeung-Hee Chang
Seung-Hee Chang
AMArash Minai-Tehrani
Arash Minai-Tehrani
YKYeon-Soo Kim
Yeon-Soo Kim
MCMyung-Haing Cho
Myung-Haing Cho
Background: The long-term survival of lung cancer patients treated with conventional therapies remains poor and has changed little in decades. The need for novel approaches remains urgent. Aerosol-mediated delivery of genes has potential for the treatment of a broad spectrum of pulmonary disorders and may offer numerous advantages over invasive modes of delivery. Methods: The potential effects of aerosol-delivered lentiviral-based short hairpin AIMP2 lacking exon 2 (shDX2) on lung tumorigenesis were studied. Lentiviral-based shDX2 was delivered into AIMP2+/– mice through a nose-only inhalation system twice a week for 4 weeks. Results and Conclusions: The effects of shDX2 on lung cancer progression and the Akt1-mTOR-p70S6K signaling pathway were evaluated. Long-term repeated delivery of lentiviral-based shDX2 suppressed lung tumor progression significantly by inhibiting Akt1-related signals and decreasing both protein synthesis and angiogenesis. In vivo, the aerosol-mediated application of lentiviral-based short hairpin RNAs was successful in achieving potent and specific knockdown of the target. The collective results indicate the therapeutic potential of the repeated delivery of shDX2 for lung cancer treatment and prevention.

17 March 2024 in Cells
Verified
Journal Article
Open access
PDF file
SHSo Young Ham
So Young Ham
MPMINJU PYO
MINJU PYO
MKMoonkyung Kang
Moonkyung Kang
YKYeon-Soo Kim
Yeon-Soo Kim
DLDong Hun Lee
Dong Hun Lee
SLSeung-Taek Lee
Seung-Taek Lee
Heat shock protein 47 (HSP47), also known as SERPINH1, functions as a collagen-specific molecular chaperone protein essential for the formation and stabilization of the collagen triple helix. Here, we delved into the regulatory pathways governed by HSP47, shedding light on collagen homeostasis. Our investigation revealed a significant reduction in HSP47 mRNA levels in the skin tissue of older mice as compared to their younger counterparts. The augmented expression of HSP47 employing lentivirus infection in fibroblasts resulted in an increased secretion of type I collagen. Intriguingly, the elevated expression of HSP47 in fibroblasts correlated with increased protein and mRNA levels of type I collagen. The exposure of fibroblasts to IRE1α RNase inhibitors resulted in the reduced manifestation of HSP47-induced type I collagen secretion and expression. Notably, HSP47-overexpressing fibroblasts exhibited increased XBP1 mRNA splicing. The overexpression of HSP47 or spliced XBP1 facilitated the nuclear translocation of β-catenin and transactivated a reporter harboring TCF binding sites on the promoter. Furthermore, the overexpression of HSP47 or spliced XBP1 or the augmentation of nuclear β-catenin through Wnt3a induced the expression of type I collagen. Our findings substantiate that HSP47 enhances type I collagen expression and secretion in fibroblasts by orchestrating a mechanism that involves an increase in nuclear β-catenin through IRE1α activation and XBP1 splicing. This study therefore presents potential avenues for an anti-skin-aging strategy targeting HSP47-mediated processes.

18 October 2023 in BMB Reports
Verified
Journal Article
Open access
PDF file
HCHyunji Choi
Hyunji Choi
MKMoonkyung Kang
Moonkyung Kang
KLKee-Ho Lee
Kee-Ho Lee
YKYeon-Soo Kim
Yeon-Soo Kim
Hyunji Choi, Moonkyung Kang, Kee-Ho Lee & Yeon-Soo Kim. BMB Reports 2023;56:612-7. https://doi.org/10.5483/BMBRep.2023-0162